These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22696266)

  • 1. Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial.
    Firsching R; Piek J; Skalej M; Rohde V; Schmidt U; Striggow F;
    J Neurol Surg A Cent Eur Neurosurg; 2012 Aug; 73(4):204-16. PubMed ID: 22696266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of gacyclidine. A multicenter double-blind pilot trial in patients with acute traumatic brain injury.
    Lepeintre JF; D'Arbigny P; Mathé JF; Vigué B; Loubert G; Delcour J; Kempf C; Tadié M
    Neurochirurgie; 2004 Jun; 50(2-3 Pt 1):83-95. PubMed ID: 15213636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.
    Wright DW; Kellermann AL; Hertzberg VS; Clark PL; Frankel M; Goldstein FC; Salomone JP; Dent LL; Harris OA; Ander DS; Lowery DW; Patel MM; Denson DD; Gordon AB; Wald MM; Gupta S; Hoffman SW; Stein DG
    Ann Emerg Med; 2007 Apr; 49(4):391-402, 402.e1-2. PubMed ID: 17011666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Ultrahigh" dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group.
    Gaab MR; Trost HA; Alcantara A; Karimi-Nejad A; Moskopp D; Schultheiss R; Bock WJ; Piek J; Klinge H; Scheil F
    Zentralbl Neurochir; 1994; 55(3):135-43. PubMed ID: 7810251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
    Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH
    Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.
    Marmarou A; Nichols J; Burgess J; Newell D; Troha J; Burnham D; Pitts L
    J Neurotrauma; 1999 Jun; 16(6):431-44. PubMed ID: 10391361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy.
    Olivecrona M; Koskinen LO
    Acta Neurochir (Wien); 2012 Sep; 154(9):1567-73. PubMed ID: 22543506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial.
    Temkin NR; Anderson GD; Winn HR; Ellenbogen RG; Britz GW; Schuster J; Lucas T; Newell DW; Mansfield PN; Machamer JE; Barber J; Dikmen SS
    Lancet Neurol; 2007 Jan; 6(1):29-38. PubMed ID: 17166799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction.
    Ostenfeld T; Price J; Albanese M; Bullman J; Guillard F; Meyer I; Leeson R; Costantin C; Ziviani L; Nocini PF; Milleri S
    Clin J Pain; 2011 Oct; 27(8):668-76. PubMed ID: 21540741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
    Schmidt W; Schäfer F; Striggow V; Fröhlich K; Striggow F
    Neuroscience; 2012 Dec; 227():313-26. PubMed ID: 23069763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure.
    Oddo M; Levine JM; Mackenzie L; Frangos S; Feihl F; Kasner SE; Katsnelson M; Pukenas B; Macmurtrie E; Maloney-Wilensky E; Kofke WA; LeRoux PD
    Neurosurgery; 2011 Nov; 69(5):1037-45; discussion 1045. PubMed ID: 21673608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Lund concept versus cerebral perfusion pressure-targeted therapy: a randomised controlled study in patients with secondary brain ischaemia.
    Dizdarevic K; Hamdan A; Omerhodzic I; Kominlija-Smajic E
    Clin Neurol Neurosurg; 2012 Feb; 114(2):142-8. PubMed ID: 22036839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief episodes of intracranial hypertension and cerebral hypoperfusion are associated with poor functional outcome after severe traumatic brain injury.
    Stein DM; Hu PF; Brenner M; Sheth KN; Liu KH; Xiong W; Aarabi B; Scalea TM
    J Trauma; 2011 Aug; 71(2):364-73; discussion 373-4. PubMed ID: 21825940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study.
    Mazzeo AT; Alves OL; Gilman CB; Hayes RL; Tolias C; Niki Kunene K; Ross Bullock M
    Acta Neurochir (Wien); 2008 Oct; 150(10):1019-31; discussion 1031. PubMed ID: 18781275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentobarbital coma for refractory intra-cranial hypertension after severe traumatic brain injury: mortality predictions and one-year outcomes in 55 patients.
    Marshall GT; James RF; Landman MP; O'Neill PJ; Cotton BA; Hansen EN; Morris JA; May AK
    J Trauma; 2010 Aug; 69(2):275-83. PubMed ID: 20699736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil.
    Bourgoin A; Albanèse J; Wereszczynski N; Charbit M; Vialet R; Martin C
    Crit Care Med; 2003 Mar; 31(3):711-7. PubMed ID: 12626974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
    Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
    Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial pressure monitoring in brain-injured patients is associated with worsening of survival.
    Shafi S; Diaz-Arrastia R; Madden C; Gentilello L
    J Trauma; 2008 Feb; 64(2):335-40. PubMed ID: 18301195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
    Maas AI; Murray G; Henney H; Kassem N; Legrand V; Mangelus M; Muizelaar JP; Stocchetti N; Knoller N;
    Lancet Neurol; 2006 Jan; 5(1):38-45. PubMed ID: 16361021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothermia therapy after traumatic brain injury in children.
    Hutchison JS; Ward RE; Lacroix J; Hébert PC; Barnes MA; Bohn DJ; Dirks PB; Doucette S; Fergusson D; Gottesman R; Joffe AR; Kirpalani HM; Meyer PG; Morris KP; Moher D; Singh RN; Skippen PW;
    N Engl J Med; 2008 Jun; 358(23):2447-56. PubMed ID: 18525042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.